Pre Clinical
Research payments
$15,061,536
Through program year 2025, $15,061,536 in research payments was reported against Pre Clinical, across 67 payments.
- Paid by (largest first)
- Pfizer Inc.; Parkedale Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $7,359,664 | 17 |
| 2023 | Research | $7,535,577 | 33 |
| 2022 | Research | $63,581 | 11 |
| 2021 | Research | $267 | 2 |
| 2020 | Research | $83,367 | 2 |
| 2019 | Research | $19,080 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alexander Greninger Seattle, WA Named on 5 payments
- William Sellers Cambridge, MA Named on 3 payments
- Alan Michelson Boston, MA Named on 2 payments
- Timothy Nichols Chapel Hill, NC Named on 1 payment
- Andrew Cole Boston, MA Named on 1 payment
- Gregory Longmore Saint Louis, MO Named on 1 payment
- Marc Hellerstein Kensington, CA Named on 1 payment
- Ryan Ahern Seattle, WA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.